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Abstract
Background: Case studies and anecdotal reports have documented a range of acute illnesses associated with exposure
to cyanobacteria and their toxins in recreational waters. The epidemiological data to date are limited; we sought to
improve on the design of some previously conducted studies in order to facilitate revision and refinement of guidelines
for exposure to cyanobacteria in recreational waters.
Methods: A prospective cohort study was conducted to investigate the incidence of acute symptoms in individuals
exposed, through recreational activities, to low (cell surface area <2.4 mm2/mL), medium (2.4–12.0 mm2/mL) and high
(>12.0 mm2/mL) levels of cyanobacteria in lakes and rivers in southeast Queensland, the central coast area of New South
Wales, and northeast and central Florida. Multivariable logistic regression analyses were employed; models adjusted for
region, age, smoking, prior history of asthma, hay fever or skin disease (eczema or dermatitis) and clustering by
household.
Results: Of individuals approached, 3,595 met the eligibility criteria, 3,193 (89%) agreed to participate and 1,331 (37%)
completed both the questionnaire and follow-up interview. Respiratory symptoms were 2.1 (95%CI: 1.1–4.0) times more
likely to be reported by subjects exposed to high levels of cyanobacteria than by those exposed to low levels. Similarly,
when grouping all reported symptoms, individuals exposed to high levels of cyanobacteria were 1.7 (95%CI: 1.0–2.8)
times more likely to report symptoms than their low-level cyanobacteria-exposed counterparts.
Conclusion: A significant increase in reporting of minor self-limiting symptoms, particularly respiratory symptoms, was
associated with exposure to higher levels of cyanobacteria of mixed genera. We suggest that exposure to cyanobacteria
based on total cell surface area above 12 mm2/mL could result in increased incidence of symptoms. The potential for
severe, life-threatening cyanobacteria-related illness is likely to be greater in recreational waters that have significant
levels of cyanobacterial toxins, so future epidemiological investigations should be directed towards recreational exposure
to cyanotoxins.
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Background
Planktonic cyanobacteria are common inhabitants of
freshwater lakes and reservoirs throughout the world.
Under favourable conditions, certain cyanobacteria can
dominate the phytoplankton within a waterbody and
form nuisance blooms. The principal public health con-
cern regarding exposure to freshwater cyanobacteria
relates to the understanding that some blooms produce
toxins that specifically affect the liver or the central nerv-
ous system. Exposure routes for systemic poisoning by
these toxins are oral, from accidental or deliberate inges-
tion of recreational water, and possibly by inhalation.
A small collection of case reports and anecdotal references
dating from 1949 have described a range of illnesses asso-
ciated with recreational exposure to cyanobacteria: hay
fever-like symptoms, pruritic skin rashes and gastro-intes-
tinal symptoms are most frequently reported. Some
papers give convincing descriptions of allergic responses
to cyanobacteria; others describe more serious acute ill-
nesses, with symptoms such as severe headache, pneumo-
nia, fever, myalgia, vertigo and blistering in the mouth.
Anecdotal and case reports and the epidemiology of recre-
ational exposure to freshwater cyanobacteria were
recently reviewed by Stewart et al [1]. Under-reporting of
minor, self-limiting illnesses may explain the small
number of anecdotal and case reports in the literature.
Moreover, a knowledge gap about cyanobacteria probably
exists for many primary health care providers. Epidemio-
logical studies into recreational exposure to cyanobacteria
are also few in number. Five have been published to date:
three cross-sectional studies from the United Kingdom
using identical survey instruments [2-4], a small case-con-
trol analysis from Australia [5], and a larger prospective
cohort study, also from Australia [6]. The UK studies and
the smaller Australian study did not find any significant
hazard from exposure to cyanobacterial blooms in recrea-
tional waters, but the study by Pilotto et al [6] reported an
increase in illness amongst those exposed to relatively low
levels of cyanobacteria (>5,000 cells per mL) compared to
unexposed individuals.
Despite this limited and inconclusive evidence, the World
Health Organization (WHO), Australia and several Euro-
pean countries have recommended guideline levels for
recreational exposure to cyanobacteria [[7] (pp.149–54),
[8]]. WHO guidelines present a three-tier approach, sug-
gesting: 1) low probability of adverse health effects from
waters with 20,000 cyanobacterial cells/mL or 10 μg chlo-
rophyll-a/L (if cyanobacteria are dominant); 2) moderate
probability of adverse effects from waters with 100,000
cells/mL or 50 μg chlorophyll-a/L; and 3) high probability
of adverse effects from contact with and/or ingestion/aspi-
ration of cyanobacteria at scum-forming densities [[7]
(p.150)]. There is concern, however, that the current man-
agement practice in some countries (such as Australia or
Germany) of warning all users or closing access to water-
bodies is overly proscriptive. Such practices can result in
unease amongst regular users of recreational waters that
are affected by cyanobacteria, and can impact communi-
ties surrounding these waters, which are important social
and economic resources.
Due to the small number of published epidemiology
studies and the need for revision and refinement of recre-
ational water exposure guidelines relating to planktonic
cyanobacteria, we conducted a prospective cohort study to
investigate morbidity following recreational exposure to
cyanobacteria. Specifically, we sought to: 1) quantify cya-
notoxins in designated water recreation sites, and 2)
assess the relationship between exposure to cyanobacteria
and cyanotoxins in recreational waters and the incidence
of reported symptoms.
Methods
The study population of interest comprised adults and
children engaging in recreational activities in enclosed
waters (i.e. not marine waters) inhabited to varying
degrees by planktonic cyanobacteria. Subjects were
recruited over a three-year period from 1999 to 2002 at
water recreation sites in southern Queensland and the
Myall Lakes area of New South Wales (Australia), and
northeast and central Florida (USA). Recruitment was
conducted on 54 separate days, mostly on weekends and
holiday periods during the warmer months in order to
maximise recruitment efficiency by concentrating on
peak-use periods of recreational activity.
Entry criteria into the study were twofold:
￿ Engaging or planning to partake in water-contact activi-
ties in the study water body on the day of recruitment –
ascertained by asking "Is anybody in the vehicle planning
to go in the water and get wet here today?"
￿ Able to be contacted by phone for follow-up.
Study subjects were enrolled at the water sites and asked
to complete a self-administered questionnaire before leav-
ing for the day. They were also asked to submit to a tele-
phone follow-up interview to be conducted as soon as
practicable after three days from the day of enrolment.
The interviewers asked to speak to study subjects within
each household individually, i.e. proxy interviewees were
discouraged. Exceptions were made in the case of chil-
dren, where a parent or guardian was asked to decide
whether or not their child would participate in the follow-
up directly.BMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
Page 3 of 11
(page number not for citation purposes)
The questionnaire, follow-up interview form and infor-
mation letter are available in Stewart [[9] (Appendix 1)].
The questionnaire gathered basic demographic data,
information about relevant chronic conditions (chiefly
allergies) and recent acute illnesses, as well as details of
water-related activities. The follow-up interview elicited
information about various acute illnesses, their onset and
severity as well as smoking status, water exposure in the
follow-up period and within-household grouping of
study subjects.
Written permission (gatekeeper approval) from manage-
ment authorities to recruit members of the public into this
study was sought and secured for all sites listed in Table 1.
The study was approved by the University of Queens-
land's Behavioural and Social Sciences Ethical Review
Committee (clearance number B/168/SocPrevMed/99/
PhD) and the University of Miami Human Subjects Com-
mittee (protocol number 02/031A).
Table 1 lists the main characteristics of the study sites.
Some sites that were initially identified as potential study
sites on the basis of cyanobacteria monitoring programs
were subsequently found to have low cyanobacteria meas-
ures at the time of subject recruitment, and were thus clas-
sified as reference sites. Two sites served as both study and
reference sites due to variability in cyanobacterial densi-
ties over several recruitment visits. Figure 1 is an aerial
photograph of a recent cyanobacteria bloom affecting one
of the study areas.
Water samples for phytoplankton and cyanotoxin analy-
sis were collected by a modified grab sample method.
Polypropylene sample bottles were used to collect water at
Table 1: Recreational waters visited for recruitment of study subjects
SITE REGION DESCRIPTION POWERED
WATERCRAFT
PECULIAR 
FEATURES
(S)TUDY OR
(R)EFERENCE SITE
PLANNED ACTUAL
Logan Inlet – 
Lake Wivenhoe
South-east Queensland Large water-supply 
storage
No S S + R
Kirkleagh – Lake 
Somerset
South-east Queensland Large water-supply 
storage
Yes S R
The Spit – Lake 
Somerset
South-east Queensland Large water-supply 
storage
Yes S S + R
Brown Lake – 
Nth Stradbroke 
Island
South-east Queensland Small dune lake No Acidic perched lake 
(pH 4.6 – 4.7)
RR
Atkinson Dam South-east Queensland Small irrigation storage Yes S S
Natural Arch South-east Queensland Upper catchment stream No Water temperature 
lowest of all sites
RR
College's 
Crossing
South-east Queensland Shallow river – release 
water from Wivenhoe 
Dam
No R R
Currumbin Rock 
Pool
South-east Queensland Lower catchment stream No Dairy farms in 
catchment – faecal 
coliform counts often 
high
RR
Bombah 
Broadwater
Myall Lakes NSW Large saline enclosed lake Yes S R
Myall Lake Myall Lakes NSW Large brackish water lake No S S
Smith's Lake Myall Lakes NSW Small saline enclosed lake Yes R R
Lake Coolmunda Southern Queensland Small irrigation storage Yes S S
Hickory Point – 
Little Lake Harris
Central Florida Chain of connected inland 
lakes
Yes S S
Manatee Springs North/central Florida Freshwater spring 
bulkhead
No R R
Fanning Springs North/central Florida Freshwater spring 
bulkhead
No R R
Lake Seminole West/central Florida Artificial lake in densely 
developed area
Yes S S
Doctors Lake North-east Florida Tidal influenced tributary 
lake of the St Johns River
Yes S S
Lake Cannon Central Florida Small urban lake Yes S S
Lake Shipp Central Florida Small urban lake Yes S SBMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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a depth of approximately 70 cm; the modification
involved moving the sample bottle up and down in a ver-
tical plane to sample water through the entire column in
order to avoid spurious cyanobacteria estimates through
sampling only surface water. In an attempt to address tem-
poral and spatial heterogeneity of cyanobacteria profiles
within each waterbody, samples were collected from
between one and four locations on each recruitment day,
depending on the size of the site. Samples were collected
in the morning and afternoon. All samples were kept on
ice, in darkness, and equal volumes were then pooled
prior to leaving the site to form a composite sample. Com-
posite samples were immediately fixed with Lugol's
iodine, then stored at 4°C until examined. Separate water
samples were collected for cyanotoxin analysis; these sam-
ples were also stored at 4°C but were not fixed.
Sub-surface samples for faecal coliform analysis were col-
lected in 250 mL sterile containers shortly before depart-
ing each site; containers were immediately placed on ice,
and stored at 4°C until analysed. Due to logistical issues,
faecal coliforms were sampled only when a recruitment
visit was followed by a routine working day. Of the 54
study sampling days, coliform sampling was conducted
on 21 days (i.e. 39% of exposure events included faecal
coliform analysis).
Total phytoplankton analyses were conducted at three
separate laboratories due to contractual obligations of the
various agencies that funded this work: Queensland
Health Scientific Services, Brisbane (National Association
of Testing Authorities [NATA] accredited) for all Queens-
land samples; Australian Water Technologies, West Ryde,
NSW (NATA accredited) for all Myall Lakes area samples;
CyanoLab, Palatka, Florida for all Florida samples.
Cell identification and enumeration at these three centres
were conducted by broadly similar methods, using a cali-
brated counting chamber with phase-contrast micros-
copy. Cell surface areas were determined by defining
cyanobacteria cells as spherical or cylindrical, then meas-
uring cell diameter (all cells) and length (idealised cylin-
Aerial image showing a yacht traversing a Microcystis bloom, St Johns River, Florida, August 2005 Figure 1
Aerial image showing a yacht traversing a Microcystis bloom, St Johns River, Florida, August 2005. Image copyright Bill Yates / 
CYPIX 2005.BMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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drical cells). An appropriate number of cells were
measured, and then averaged to give dimensions for each
cyanobacterial taxon in each water sample. Cell surface
areas were calculated using the formulas S.A. = 4πr2 (ide-
alised spherical cells), or S.A. = 2(πr2) + (2πr)l (idealised
cylindrical cells) where v = cell volume; r = cell radius; l =
cell length; S.A. = cell surface area. Data for each cyano-
bacterial taxon were summed, and total cyanobacterial
cell surface area was used as the measure of exposure for
each recruitment day in subsequent statistical analyses.
Samples that contained potentially toxic cyanobacteria
were analysed for specific cyanotoxins:
￿ Microcystins : Microcystis spp, Anabaena spp, Planktothrix
spp,
￿ Saxitoxins (Australia only): Anabaena circinalis
￿ Cylindrospermopsin: Cylindrospermopsis raciborskii, Aph-
anizomenon ovalisporum
￿ Anatoxin-a: (Florida only): Anabaena spp, C. raciborskii
Australian samples were analysed at Queensland Health
Scientific Services laboratories. Saxitoxins were analysed
by high performance liquid chromatography (HPLC)
with fluorescence detection using a Shimadzu LC-10AVP
system (Shimadzu Corp, Japan) based on the methods of
Lawrence et al [10]; microcystins were measured by a Shi-
madzu LC-10A HPLC with photodiode array detection
using the methods of Lawton et al [11]. Cylindrosper-
mopsin was quantified by HPLC-MS/MS with a Perkin
Elmer series 200 HPLC (Perkin Elmer Corp, USA) coupled
to a PE SCIEX API 300 mass spectrometer (PE SCIEX, Can-
ada) [12]. In Florida, toxins were analysed at CyanoLab.
Cylindrospermopsin and anatoxin-a were determined by
a HPLC-MS/MS method on a ThermoFinnigan LCQ
Advantage system (ThermoFinnigan, USA). Microcystins
were determined by an enzyme-linked immunosorbent
assay method with a commercially available kit from
Abraxis LLC (product # 520011, Abraxis LLC, USA).
All faecal coliform samples were analysed within 24 hours
following collection. Samples were analysed at the follow-
ing laboratories: Queensland Health Scientific Services,
Brisbane, QLD (NATA accredited): method # AS 4276.7
(Australian Standard method for thermotolerant colif-
orms and Escherichia coli – membrane filtration method);
Centre for Integrated Environmental Protection, Griffith
University, Brisbane, QLD: method # APHA 9222D
(APHA membrane filtration method); Forster Environ-
mental Laboratory, Forster, NSW (NATA accredited):
method # APHA 9222D; Columbia Analytical Services,
Jacksonville, Florida (NELAC accredited): method # SM
9222D (USEPA Standard Method – membrane filtration
method).
Water conductivity was measured at Australian study sites
with an integrated conductivity/pH/temperature meter
(Model WP-81, TPS P/L, Australia). In Florida, conductiv-
ity was recorded with a DataSonde MP 6600 (YSI Inc,
USA).
Data analysis
Cyanobacterial cell surface area was chosen as the princi-
pal exposure variable of interest [[9] (Chapter 3)] and
classified as low (total cyanobacterial cell surface area
<2.4 mm2/mL), intermediate (2.4–12.0 mm2/mL) and
high (>12.0 mm2/mL) based on guidelines from the
Queensland Department of Natural Resources and Mines
[[9] (Chapter 3), [13]]. Faecal coliform exposures were
categorised as positive or negative according to the Aus-
tralian and New Zealand regulatory guidelines for fresh
and marine water quality [14]. Participants were catego-
rised into five age groups (see Table 2) and as active, pas-
sive or non-smokers. Passive smokers were defined as
non-smokers or children aged less than 12 years who lived
in a dwelling where at least one other household member
smoked inside the house. Faecal coliform counts can fluc-
tuate on a daily or weekly basis, so analyses including col-
iform data were conducted only on the sub-sets of the
cohort for which these readings were available for the day
of recruitment.
The dependent variable for all analyses was symptom
reporting; symptoms were pooled into an "any symptom"
category, and because of the disparate nature of symp-
toms associated with cyanobacteria exposure [1], reported
symptoms were categorised as ear (sore ear/s; discharge
Table 2: Demographic characteristics of the entire study cohort.
n (%)
Age (years)
<12 312 (23)
13–24 346 (26)
25–39 375 (28)
40–54 256 (19)
>55 42 (3)
Sex
Female 635 (48)
Male 696 (52)
Region
Florida 216 (16)
New South Wales 300 (23)
Queensland 815 (61)
Smoking status
Non smoker 953 (72)
Passive smoker 131 (10)
Smoker 247 (19)BMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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from ear/s), eye (sore eye/s; eye redness; discharge from
eye/s; itchy eye/s), gastro-intestinal (G-I) (vomiting; diar-
rhoea; abdominal pain; nausea), respiratory (difficulty
breathing; dry cough; productive cough; runny nose; unu-
sual sneezing; sore throat; wheezy breathing), cutaneous
(skin rash; redness of the skin not related to sunburn;
unusual itchiness), fever (single sign/symptom of fever)
and the combined "any symptom" (any of the above).
Respondents were asked to rate symptoms that occurred
in the follow-up period as mild, moderate or severe. The
number of symptoms reported as "severe" was, however,
very low so this category was combined with "moderate",
to form a single category. Subjects were excluded from
specific analyses if they reported one or more associated
acute symptoms had started before recruitment into the
study.
Pearson's chi-squared test and Fisher's exact test were used
to compare group proportions, while logistic regression
was used to investigate associations between symptom
variables and cyanobacterial exposure after accounting for
potential confounding variables and geographic region,
which was a design variable in all logistic regression mod-
els. A multivariable logistic regression main-effects model
was developed, using sequential backward elimination of
non-significant variables (based on the model deviance
statistic). Once the most parsimonious main-effects
model was identified, all two-factor interactions were
introduced into the model and stepwise elimination of
non-significant terms was undertaken (again based on the
model deviance statistic) until the final model was
obtained. The final model adjusted for age, sex, smoking
and reported prior history of asthma, hay fever or eczema.
A second multivariable model was developed for the "any
symptoms" outcome by excluding subjects who reported
exposure at the study waterbody in the five-day period
prior to recruitment, as per the work of Pilotto et al [6].
SPSS v11.5 [15], Epi Info v6.O4d [16] and Stata/SE v8.0
[17] were used for statistical analyses and a significance
level of α = 0.05 was used to define statistical significance.
Results and discussion
The study entry criteria were met by 3,595 individuals; of
these, 402 (11%) refused to participate in the study. Of
the 3,193 people who accepted a questionnaire, 1,371
(43%) returned it. Of these, 40 individuals did not com-
plete the follow-up interview for various reasons (uncon-
tactable, refused). The 1,331 subjects with follow-up data
thus represented 42% of those who initially accepted a
questionnaire. Demographic features of the cohort are
shown in Table 2. The majority of participants were from
Queensland; most were less than 55 years of age and non-
smokers.
Table 3 presents the proportion of subjects reporting
symptoms at each level of cyanobacteria exposure. There
were no significant differences between the frequency and
reported severity of symptoms over the three cyanobacte-
ria exposure groups. For further analyses, we collapsed the
symptom variables into two groups of "not reported" and
"reported at any severity". This dichotomisation also
increased the robustness of the statistical modelling.
Table 4 presents the results of crude and multivariable
logistic modelling. Two statistically significant findings
were identified: compared to the low exposure group,
reporting of both respiratory symptoms, odds ratio (OR)
2.1 (95%CI: 1.1–4.0), and the pooled "any symptom",
OR 1.7 (95%CI: 1.0–2.9), was increased in the high expo-
sure group. However, the significance of the latter result
was not maintained with the exclusion of subjects with
recent prior recreational water exposure, OR 1.6 (95%CI:
0.8–3.2).
Analysis of cyanotoxins in study waters showed that these
were infrequently seen and, when seen, were at low levels.
Microcystins were only detected on two occasions, at 1 μg/
L (Doctors Lake) and 12 μg/L (Lake Coolmunda); cylin-
drospermopsin was found on seven occasions (Lakes
Wivenhoe, Somerset, Atkinson and Seminole), but the
levels were low at 1 μg/L and 2 μg/L. Saxitoxins were not
seen in this study, and anatoxin-a was only detected at one
Florida site (Lake Seminole) on a single recruitment day,
at 1 μg/L. A statistically significant increase in symptom
reporting amongst Florida subjects exposed to anatoxin-a
was found by the Fisher-Freeman-Halton test (p = 0.04),
but the number of subjects exposed (n = 18) was very low.
No relationship was seen between faecal coliform counts
in study waters and symptom reporting: G-I symptoms (p
= 0.50), respiratory symptoms (p = 0.92) and the pooled
"any symptom" category (p = 0.96). Therefore we have no
evidence that observed variation in symptom reporting
could be attributed to differential exposure to enteric
pathogens. However, our ability to monitor all recruit-
ment days (mostly conducted on weekends and public
holidays) for faecal coliforms was limited because the of
the 24-hour maximum allowable time between sample
collection and testing.
The main findings of this work were that individuals
exposed to recreational waters from which total cyanobac-
terial cell surface areas exceeded 12 mm2/mL were more
likely to report symptoms, particularly respiratory symp-
toms, after exposure than those exposed to waters where
cyanobacterial cell surface areas were less than 2.4 mm2/
mL. The measured effect size was similar but non-signifi-
cant for ear and cutaneous symptoms, fever and all symp-
toms after exclusion of subjects with prior site exposure,BMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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which suggests that the sample sizes were too small to
show significant differences within these categories. No
relationship was detected between exposure to intermedi-
ate levels of cyanobacteria (total cell surface area 2.4–12.0
mm2/mL) and symptom reporting.
Although the symptom category that appeared to be
weighting the pooled "any symptom" category was that of
respiratory symptoms, from Table 3 we see that respira-
tory symptom reporting was skewed towards the "mild"
symptom rating. Therefore, the conclusion that symptom
reporting was higher in individuals exposed to high
cyanobacteria levels must be tempered by the observation
that most reported respiratory symptoms were mild.
This study attempted to improve on some study design
weaknesses of previously published work in this field. The
control group was recruited at waters known or suspected
to be substantially free of cyanobacteria. We were con-
cerned that the control subjects (i.e. non-bathers) in the
studies of Pilotto et al [6] and Philipp [2], Philipp & Bates
[3] and Philipp et al [4] might differ in some way from
those who chose to go in the water. They might also tend
to under-report relevant illnesses, given the propensity of
some people to give the kind of answers that they think
health researchers are seeking [18]. There is a risk that
some individuals who are non-bathers, when presented
with questions that are obviously concerned with water-
related activities, might tend to downplay symptoms that
they correctly assume are unrelated to water contact and
then incorrectly assume to be of no interest to researchers.
A control group of bathers also accounts for possible
effects of water immersion that may be unrelated to water
quality. Such effects may also lead to under-estimation of
swimming-related illness when non-bathers comprise the
unexposed comparison group [19].
We also measured cyanotoxins in study waters directly by
HPLC-based methods. In previous studies cyanotoxins
were either not considered or indirect and unquantified
measures of cyanotoxin presence were used. However, the
cyanotoxins were infrequently seen at study waters and,
where seen, were at universally low levels. While we
observed a significant increase in symptom reporting
amongst Florida subjects exposed to anatoxin-a, the
number of subjects exposed was very low, so we were
reluctant to draw any conclusions from this finding. The
infrequent presence and low concentrations of cyanotox-
ins in study waters highlights one of the disadvantages in
conducting a prospective cohort study, that cyanobacteria
Table 3: Frequency (percentage) of subjects reporting symptoms against level of cyanocyanobacteria exposure: low (cell surface area 
<2.4 mm2/mL), intermediate (2.4 – 12.0 m 12.0 mm2/mL) and high (>12.0 mm2/mL).
Symptoms Cyanobacteria exposure
Low n(%) Intermediate n(%) High n(%) p-value
Any symptom 0.42
None 569 (70) 134 (74) 99 (67)
Mild 147 (18) 28 (16) 34 (23)
Moderate/severe 94 (12) 18 (10) 14 (10)
Ear symptoms 0.75
None 895 (96) 199 (98) 159 (96)
Mild 21 (2) 3 (2) 4 (2)
Moderate/severe 12 (1) 1 (1) 3 (2)
Eye symptoms 0.75
None 872 (94) 196 (95) 154 (95)
Mild 41 (4) 5 (2) 6 (4)
Moderate/severe 18 (2) 5 (2) 3 (2)
Gastro-intestinal 
symptoms
0.89
None 871 (94) 199 (95) 158 (95)
Mild 30 (3) 5 (2) 5 (3)
Moderate/severe 27 (3) 5 (2) 3 (2)
Respiratory 
symptoms
0.57
None 691 (86) 169 (88) 122 (82)
Mild 87 (11) 19 (10) 22 (15)
Moderate/severe 29 (4) 5 (3) 5 (3)
Cutaneous 
symptoms
0.52
None 875 (95) 197 (96) 159 (96)
Mild 23 (3) 6 (3) 6 (4)
Moderate/severe 20 (2) 2 (1) 1 (1)BMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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and especially cyanotoxin levels are often dynamic and
therefore unpredictable.
We chose a biomass estimate – cell surface area – to deter-
mine exposure to cyanobacteria, rather than the tradi-
tional reporting method of cell counts per unit volume of
water [[9] (Chapter 3)]. Cyanobacteria cells can vary con-
siderably in size, so measuring only cell counts will over-
estimate cyanobacterial biomass if picoplankton are
dominant. Some workers recommend cyanobacterial bio-
volume or chlorophyll-a (if cyanobacteria dominate the
phytoplankton profile) as estimates of cyanobacterial
standing crop or for exposure guidelines [13,20].
We also analysed some study water samples for faecal
indicator bacteria. Previous studies which did not incor-
porate such monitoring would have been unable to elim-
inate the potential contribution of enteric pathogens to
specific symptom reporting.
The cohort was large enough to detect increased odds of
symptom reporting in the "any symptom" and respiratory
symptom categories amongst subjects exposed to high
compared to low levels of cyanobacteria. Effects of similar
magnitude were also seen for ear and skin symptoms and
fever, as well as for symptom reporting after exclusion of
subjects with recent prior exposure to study waters but
Table 4: Frequency (percentage) and binary logistic regression estimates of crude and multivariable O.R. and associated 95% 
confidence intervals (95%CI).
Exposure Symptoms
Cyanobacterial cell 
surface area1
None Present Crude models2 Multivariable3
n (%) n (%) O.R. (95%CI) O.R. (95%CI)
Any symptom
Low 569 (70) 241 (30) 1 1
Intermediate 134 (74) 46 (26) 0.8 (0.6–1.2) 0.8 (0.6–1.3)
High 99 (67) 48 (33) 1.6 (1.0–2.7) 1.7 (1.0–2.9)
Ear symptoms
Low 895 (96) 33 (4) 1 1
Intermediate 199 (98) 4 (2) 0.6 (0.2–1.5) 0.5 (0.2–1.5)
High 159 (96) 7 (4) 1.9 (0.6–6.5) 2.0 (0.6–7.1)
Eye symptoms
Low 872 (94) 59 (6) 1 1
Intermediate 196 (95) 10 (5) 0.8 (0.4–1.8) 0.8 (0.4–1.9)
High 154 (95) 9 (6) 0.6 (0.2–1.6) 0.6 (0.3–1.7)
G-I symptoms
Low 871 (94) 57 (6) 1 1
Intermediate 199 (95) 10 (5) 0.9 (0.4–1.7) 0.9 (0.4–1.8)
High 158 (95) 8 (5) 0.9 (0.3–2.2) 0.9 (0.4–2.2)
Respiratory symptoms
Low 691 (86) 116 (14) 1 1
Intermediate 169 (88) 24 (12) 1.0 (0.6–1.6) 0.9 (0.6–1.6)
High 122 (82) 27 (18) 2.0 (1.1–3.7) 2.1 (1.1–4.0)
Cutaneous symptoms
Low 875 (95) 43 (5) 1 1
Intermediate 197 (96) 8 (4) 0.7 (0.3–1.7) 0.7 (0.3–1.8)
High 159 (96) 7 (4) 1.9 (0.9–4.3) 1.9 (0.9–4.4)
Fever
Low 938 (99) 10 (1) 1 1
Intermediate 208 (99) 3 (1) 1.5 (0.4–5.6) 1.8 (0.5–6.7)
High 165 (99) 2 (1) 2.0 (0.5–8.7) 1.8 (0.4–8.1)
Any symptom – after exclusion of subjects with recent (5 days prior to recruitment) exposure
Low 436 (67) 200 (31) 1 1
Intermediate 74 (69) 33 (31) 0.9 (0.6–1.5) 0.9 (0.6–1.5)
High 71 (69) 32 (31) 1.5 (0.8–2.9) 1.6 (0.8–3.2)
1: Low = <2.4 mm2/mL; intermediate = 2.4 - 12.0 mm2/mL; high = >12.0 mm2/mL
2: Adjusted for geographic region (QLD, NSW, Florida) as a design variable and clustered by household
3: Adjusted for geographic region (QLD, NSW, Florida), age-group, sex, smoking and reported prior history of asthma, hay fever or eczema, and 
clustered by householdBMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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these were not statistically significant. A larger sample size
may have allowed us to confidently detect increased acute
illness reporting from these symptom sub-groups. How-
ever, as this study essentially found only minor morbidity,
the cost and effort required to conduct larger studies than
this one would appear to outweigh the benefits.
We did not see any dose-response relationships. With the
exception of a non-significant O.R. for febrile illness there
was no increased reporting of symptoms at intermediate
exposure but an increase at high exposure. One explana-
tion for this may be a threshold effect, i.e. a minimum
level of exposure is needed in order to see an effect.
This work was a study of exposures to non-toxic and
potentially toxic cyanobacteria in recreational waters, but
with essentially little or no exposure to known cyanotox-
ins. Recommendations arising from this work cannot,
therefore, be applied to situations where cyanobacterial
exotoxins are found to be in possibly hazardous concen-
trations. Using levels of toxin-producing cyanobacteria as
indirect measures of cyanotoxin presence may overesti-
mate the public health risks; exposure guidelines and
management strategies that address the potential, not
actual, presence of hazardous levels of cyanotoxins run
the risk of propagating "warning fatigue", where frequent
or permanent advisories (see Figure 2) are ignored by a
significant proportion of the public [[9] (Appendix 2),
[21]].
A more rigorous assessment of the risks will come with
regularly updated knowledge of the actual cyanotoxin
content in recreational waters. At present, this knowledge
is only obtained from testing of water samples in special-
ist cyanotoxin laboratories, which is expensive and with a
lag period measured in days. Research strategies directed
at an inexpensive, in-situ test for cyanotoxins would be
appropriate. We suggest that future work in this field
should investigate the epidemiology of recreational expo-
sure to known cyanotoxins, rather than the epidemiology
of recreational exposure to cyanobacteria per se.
When considering these results it is important to consider
potential sources of error, particularly the possibilities of
selection bias and confounding. Despite offering induce-
ments (entry into a raffle for electronic goods, camping
and boating permits) to increase participation in this
study, the target population was inherently difficult to
capture as most were healthy, young and busily engaged
in leisure activities. The relatively low response rate (42%)
means that the sample may become less representative of
the wider population. The overall response rate also var-
ied across the exposure groups with only 30% of eligible
subjects returning questionnaires at high exposure sites
compared to 43% and 44% of those at intermediate and
low cyanobacteria sites respectively (p < 0.001). This dif-
ference was due to a particularly poor response from high
exposure sites in Florida (27%). Some peculiar features of
these sites in Florida probably contributed to the response
rate, e.g. lack of swimming beaches (resulting in over-reli-
ance on subjects using powered watercraft) and increased
demand for limited parking spaces (manifested by boat-
user etiquette for rapid site entry and egress, with subse-
quently reduced priority for completing questionnaires)
[[9] (Appendix 2)]. However, assuming that those who
failed to return questionnaires were no more or less likely
to go on to develop symptoms than those who partici-
pated then, after adjusting for study region, the effect esti-
mates should not be affected.
Because nuisance and potentially harmful cyanobacteria
are cosmopolitan in distribution, and exposure guidelines
should therefore be universal, not region specific, we
combined the data from all three regions (Queensland,
NSW and Florida). Overall, 80% of highly exposed sub-
jects but only 10% of the low exposure group came from
Florida. In addition, symptom reporting was considerably
lower among Florida respondents than in Australia (OR
for all symptoms = 0.6, 95%CI: 0.4–1.1 for Florida and
0.9, 95%CI: 0.6–1.3 for NSW compared to Queensland).
Although we adjusted for region in our analyses, any
residual confounding by this variable is likely to have
weakened the true association. Of note, when we adjusted
for important factors in our multivariable models, the
symptom effect sizes associated with cyanobacteria expo-
sure were strengthened slightly, suggesting that the associ-
ations seen are unlikely to be due to confounding.
Although it is impossible to rule out other unknown con-
Example of an Australian cyanobacteria warning sign posted  at a recreational water site (with a concise, eloquent but  anonymous critique of the message?) Figure 2
Example of an Australian cyanobacteria warning sign posted 
at a recreational water site (with a concise, eloquent but 
anonymous critique of the message?).BMC Public Health 2006, 6:93 http://www.biomedcentral.com/1471-2458/6/93
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founders these would have to be strongly associated with
both exposure and symptoms in order to completely
explain the effects. We believe it unlikely that such strong
confounders exist, nonetheless the possibility remains
that unmeasured confounding variables may explain our
findings.
Conclusion
This study has shown that subjects exposed to high levels
of cyanobacteria in recreational waters, as measured by
total cell surface area, were more likely to report symp-
toms following such exposure than subjects exposed to
low levels of cyanobacteria. Respiratory symptoms were
most evident, and the reported severity of symptoms
across all groups was low. Cyanotoxins, when detected in
water samples, were present only at low concentrations
throughout the course of the study. Further work quanti-
fying the relationship between cyanotoxin levels and
health outcomes should be considered. The potential
remains for significant morbidity and possibly even mor-
tality associated with recreational exposure to cyanotox-
ins, these being highly potent water-soluble toxins.
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